Etoricoxib is a COX-2 selective inhibitor from Merck & Co. Current therapeutic indications are: treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Note that approved indications differ by country.
Physical State | Powder |
Packaging Type | Bags |
Packaging Size | 25 Kg |
Formula | C18H15ClN2O2S |
Molar mass | 358.842 g/mol |